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Finnaly, we strongly recommend to develop a different set of 
dose/volume constraints for cases that include the RNI. 
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Purpose/Objective: To investigate a Hybrid IMRT/VMAT 
technique which combines intensity modulated radiation 
therapy (IMRT) and volumetric modulated arc therapy (VMAT) 
for the treatment of non-small cell lung cancer (NSCLC).  
Materials and Methods: 2 partial arcs VMAT, 5-field IMRT and 
Hybrid IMRT/VMAT plans were created for 15 patients with 
NSCLC. The Hybrid IMRT/VMAT plans were combination of 2 
partial arcs VMAT and 5-field IMRT. The dose distribution of 
planning target volume (PTV) and organs at risk (OARs) for 
Hybrid IMRT/VMAT was compared with IMRT and VMAT. The 
monitor units (MUs) and treatment delivery time were also 
evaluated.  
Results: Hybrid IMRT/VMAT significantly improved the target 
conformity and homogeneity compared with IMRT and VMAT. 
The V30 of normal lung for hybrid plans was significantly 
lower than IMRT plans (17.7% vs 18.7%; p<0.05) and VMAT 
plans (17.7% vs 18.4%; p<0.05). The V5, V10, V30 and mean lung 
dose (MLD) of normal lung for hybrid plans were 5.1% ,7.7%, 
3.8% and 3.9% lower than those for VMAT plans, respectively 
(p<0.05). The maximum dose of spinal cord for hybrid plans 
was 5.6 Gy lower than that for IMRT plans (p<0.05). The dose 
received by esophagus and heart for hybrid plans were 
significantly lower than those for IMRT plans. The mean 
delivery time of IMRT, VMAT and hybrid plans were 280 s, 114 
s, and 327 s, respectively. The mean MUs needed for IMRT, 
VMAT and hybrid plans were 933, 512, and 737, respectively.  
Conclusions: The Hybrid IMRT/VMAT technique significantly 
improved the target conformity and homogeneity compared 
with IMRT and VMAT. It reduced V5, V10, V30 and MLD of 
normal lung compared with VMAT, and protected the OARs 
better with fewer MUs compared with IMRT. Hybrid 
IMRT/VMAT technique can be a viable radiotherapy technique 
with better plan quality. 
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Purpose/Objective: To compensate for the irregular surface 
of a patient head custom bolus is often used to get an 
acceptable dose distribution. This bolus is created on top of a 
model of the patient’s head. The current method is to create 
a mold with plaster cast. This mold is then filled with liquid 
plaster to create a model of the patient’s face. This 
procedure is, in terms of required time and comfort, not 
patient friendly. With the novel imaging method presented 
here, a digital model of the patient’s face is created with a 
real-time 3D Kinect camera within a minute without touching 
the patient. This 3D model is printed with a 3D printer. On 
top of this printed mold the bolus can be constructed as 
usual. This 3D scanning method is compared with the 
traditional procedure. 
Materials and Methods: The 3D digital model is acquired with 
a Microsoft Kinect camera (Xbox 360 Kinect Sensor) 
connected to a high end PC (Intel i7-4770 3.4 GHz, 16GB 
RAM, Radeon R9 200). The acquisition software (Kinect Fusion 
Explorer) provides 3D object scanning. The resulting 
reconstructed 3D model of the patients head is cropped and 
further prepared with in-house developed software. Finally it 
is printed using Polylactide (PLA) in a 1:1 scale, with a 3D 
printer (Orange-A420 dual extruder, 3D printservice Arnhem, 
NL).  
To evaluate the procedure we created models using the 
traditional method and the 3D printer method of the same 
patient. On top of both models a bolus is constructed. Two 





Within a minute a digital 3D model is created of the patients 
head. Directly after the imaging procedure the patient can 
leave. The figure shows the 3D printed face model on the 
right. Printing takes about 5 hours depending on the size of 
the model, layer thickness and infill percentage. This is done 
at night, no Radiotherapy Technician (RTT) has to be present. 
The traditional mold on the left was generated in 2 hours in 
total. 
The bolus constructed on the 3D printed model fits better to 
the patient then the traditional method. Smaller air caps 
were observed. Without any physical contact the patient is 
more relaxed. No construction material is used that can 
deform the shape of the patients face. Printing the model 
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takes longer than the traditional process of filling the mold 
with plaster. Although the time the patient is actually 
present for making the mold is a lot shorter and the patient 
doesn’t have to go through an invasive and uncomfortable 
procedure. 
Conclusions: The use of a 3D Kinect camera scanner in 
combination with a 3D printer to generate patient molds was 
implemented clinically in our institute. With this novel 
method patient comfort is increased significantly compared 
to the traditional method of using plaster cast since the 
patient doesn’t have to go through an invasive and 
uncomfortable procedure. Required patient time is less than 
a minute with an better accuracy. 
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Purpose/Objective: To develop a new treatment technique 
for prophylactic radiotherapy of the whole brain with 
avoidance of the hippocampi. This technique was 
implemented in our institute within the context of our 
participation in the 'Hippocampal Avoidance Prophylactic 
Cranial Irradiation' clinical trial (ClinicalTrials.gov 
NCT01780675). In this phase III multicentre trial patients with 
small cell lung cancer are randomised to receive Prophylactic 
Cranial Irradiation (PCI) with or without Hippocampal 
Avoidance (HA). 
Materials and Methods: The Hippocampal Avoidance Zone is 
defined as both hippocampi (left and right) extended with a 
margin of 5 mm. The Planning Target Volume (PTV) is defined 
as the brain extended with a margin of 4 mm minus the 
Hippocampal Avoidance Zone. The goal was to deliver 25 Gy 
to at least 95% of the PTV in 10 fractions, while sparing the 
hippocampi (mean dose < 8.5 Gy; max dose < 10 Gy) and eye 
lenses (max dose < 10 Gy). 
A coplanar VMAT technique with two dual arcs was planned 
using Pinnacle3 v9.8 (Philips). Overnight optimization was 
performed using a homemade script to repeat SmartArc 
optimizations at a 3mm dose grid until no further decrease in 
cost function was obtained. For this study, HA-PCI treatment 
plans with a controlpoint-spacing (CPS) of 4° as well as 2° 
were created for 7 patients. Subsequently, the plans were 
delivered on an Elekta linac with an Agility MLC (5mm 
leaves). Pre-treatment delivery-QA was performed by 
measuring the dose distribution using a cylindrical diode-
array phantom (Delta4, ScandiDos). The measured dose 
distributions were compared to the TPS calculations using a 
4%/2mm gamma criterion, aiming for a pass rate >95%. 
Planning parameters as well as QA measurement results were 
compared for the 4° and 2° plans. 
Results: The dose distribution of a typical HA-PCI treatment 
plan is shown in Figure 1. Planning parameters and QA 
measurement results of the 4o and 2o CPS plans for 7 patients 
are shown in Table 1. All plans achieved a homogeneous 
coverage of the PTV, while the objectives and constraints as 
defined in the study protocol were accomplished. QA 
measurements for the treatment plans with a CPS of 4° 
showed better agreement with the TPS calculations than the 
2° CPS plans, with an average pass rate of 95.4% at a 
4%/2mm gamma criterion (range 91.5 – 99.1%). 
 
 
Figure 1: Dose distribution of a clinical Hippocampal 
Avoidance Prophylactic Cranial Irradiation treatment plan, 
showing suitable coverage of the PTV (red colorwash) by the 
95% isodose level (23.75 Gy, thick yellow line), without high 
dose regions exceeding 110% (27.50 Gy), and adequate 
sparing of both hippocampi (green colorwash) at a dose level 
below 10 Gy (light blue isodose-line). 
Table 1. Planning parameters and QA measurement results of 
the 4o and 2o controlpoint spacing (CPS) plans of 7 patients. 
